Novel use of sulfonamide compound in combination with angiogenesis inhibitor

Details for Australian Patent Application No. 2006217690 (hide)

Owner Eisai R & D Management Co., Ltd.

Inventors Ozawa, Yoichi; Owa, Takashi; Hata, Naoko; Semba, Taro

Agent FB Rice

Pub. Number AU-B-2006217690

PCT Pub. Number WO2006/090928

Priority 2005-054150 28.02.05 JP

Filing date 28 February 2006

Wipo publication date 31 August 2006

Acceptance publication date 15 March 2012

International Classifications

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/404 (2006.01)

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/64 (2006.01) - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/090928 Priority application(s): WO2006/090928

15 March 2012 Application Accepted

  Published as AU-B-2006217690

12 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006217692-Novel combinational use of sulfonamide compound

2006217682-Activator for peroxisome proliferator activating receptor delta